Ligand validation:1XON

B3P: 2-[3-(2-HYDROXY-1,1-DIHYDROXYMETHYL-ETHYLAMINO)-PROPYLAMINO]-2-HYDROXYMETHYL-PROPANE-1,3-DIOL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
1XON_B3P_A_601	8%	3%	0.208	0.683	2.6	3.8	2	6	0	0	100%	0.6316
1TB7_B3P_A_601	9%	11%	0.215	0.71	1.49	2.91	3	9	0	0	100%	0.6316
1Y2D_B3P_B_801	3%	1%	0.256	0.607	3.74	3.99	2	6	0	0	100%	0.6316
6Y7D_B3P_B_902	99%	53%	0.048	0.975	0.77	1.06	-	1	1	0	100%	1
6TJK_B3P_BBB_1927	95%	59%	0.066	0.97	0.53	1.03	-	1	0	0	100%	1
4AD0_B3P_D_500	91%	39%	0.085	0.97	0.59	1.86	-	5	2	0	100%	1
7P41_B3P_D_703	89%	53%	0.073	0.95	0.83	1	-	1	0	0	100%	1
6RL0_B3P_B_701	88%	40%	0.077	0.954	0.89	1.52	-	3	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.